Intelligent Bio Solutions (INBS) Depreciation & Amortization (CF) (2023 - 2025)
Intelligent Bio Solutions (INBS) recorded quarterly Depreciation & Amortization (CF) of $301978.0 in Q1 2025, down 18.19% quarter-over-quarter from $369124.0 in Q4 2024, and up 12.9% on a YoY basis from $267464.0 in Q1 2024.
Intelligent Bio Solutions (INBS) Depreciation & Amortization (CF) (2023 - 2025) Analysis & Trends
Intelligent Bio Solutions' Depreciation & Amortization (CF) history runs 3 years deep, the most recent figure standing at $301978.0 for Q1 2025.
- In Q1 2025, Depreciation & Amortization (CF) rose 12.9% year-over-year to $301978.0; the TTM figure through Jun 2025 stood at $912724.0 (up 22.27% YoY), while the FY2025 annual figure was $14955.0, down 1.01% from the prior year.
- Depreciation & Amortization (CF) was $301978.0 for Q1 2025 at Intelligent Bio Solutions, down from $369124.0 in the prior quarter.
- In the past five years, Depreciation & Amortization (CF) ranged from a high of $369124.0 in Q4 2024 to a low of $111994.0 in Q2 2023.
- Historically, Depreciation & Amortization (CF) has averaged $265522.5 across 3 years, with a median of $257531.0 in 2023.
- Biggest YoY gain for Depreciation & Amortization (CF) was 59.49% in 2024; the steepest drop was 24.22% in 2024.
- A 3-year view of Depreciation & Amortization (CF) shows it stood at $231446.0 in 2023, then surged by 59.49% to $369124.0 in 2024, then declined by 18.19% to $301978.0 in 2025.
- The last three Depreciation & Amortization (CF) figures came in at $301978.0 (Q1 2025), $369124.0 (Q4 2024), and $241622.0 (Q3 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 381.00 Mn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 120.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 749.00 Mn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 351.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 40.90 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 67.10 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 78.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 123.40 Mn |
| 10 | Intelligent Bio Solutions | 12.67 Mn | 11.47 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 301,978.00 |
| Mar 31, 2025 | 301,978.00 |
| Dec 31, 2024 | 369,124.00 |
| Dec 31, 2024 | 369,124.00 |
| Sep 30, 2024 | 241,622.00 |
| Sep 30, 2024 | 241,622.00 |
| Mar 31, 2024 | 267,464.00 |
| Mar 31, 2024 | 267,464.00 |
| Dec 31, 2023 | 231,446.00 |
| Dec 31, 2023 | 231,446.00 |
| Sep 30, 2023 | 247,598.00 |
| Sep 30, 2023 | 247,598.00 |
| Jun 30, 2023 | 111,994.00 |
| Jun 30, 2023 | 111,994.00 |
| Mar 31, 2023 | 352,954.00 |
| Mar 31, 2023 | 352,954.00 |